Company filings profile · CIK 0001855485
Calidi Biotherapeutics, Inc. — SEC filings & insider activity.
Real, source-linked SEC EDGAR activity for Calidi Biotherapeutics, Inc. (CLDI): 16 filings in the last 90 days vs 15 in the prior 90 (filing-velocity steady · 1.07×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.
✔ Verified against the public SEC EDGAR filing record as of Sep 23, 2026. Source-linked, daily-refreshed.
Material 8-K events — Calidi Biotherapeutics, Inc.
8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).
| Filed | Event | |
|---|---|---|
| Sep 22, 2026 | Entry into a Material Agreement; Other Events; Financial Statements and Exhibits | ↗ |
| Aug 13, 2026 | Results of Operations (earnings); Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Jul 31, 2026 | Item 3.03; Amendments to Bylaws/Charter; Financial Statements and Exhibits | ↗ |
| Jul 16, 2026 | Entry into a Material Agreement; Termination of a Material Agreement; Material Direct Financial Obligation; Financial Statements and Exhibits | ↗ |
| Jun 23, 2026 | Departure/Election of Directors or Officers; Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | ↗ |
| Jun 18, 2026 | Item 5.07 | ↗ |
| May 29, 2026 | Entry into a Material Agreement; Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| May 14, 2026 | Results of Operations (earnings); Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| May 8, 2026 | Entry into a Material Agreement; Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| Apr 2, 2026 | Departure/Election of Directors or Officers; Other Events; Financial Statements and Exhibits | ↗ |
| Mar 27, 2026 | Results of Operations (earnings); Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Mar 11, 2026 | Entry into a Material Agreement; Unregistered Sale of Securities; Other Events; Financial Statements and Exhibits | ↗ |
| Feb 10, 2026 | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Jan 29, 2026 | Results of Operations (earnings); Other Events; Financial Statements and Exhibits | ↗ |
Watch Calidi Biotherapeutics, Inc. automatically
Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.
Recent filings
| Filed | Form | Detail | |
|---|---|---|---|
| Sep 22, 2026 | 8-K | Entry into a Material Agreement; Other Events; Financial Statements and Exhibits | ↗ |
| Sep 17, 2026 | 424B5 | 424B5 | ↗ |
| Aug 19, 2026 | 4 | 4 | ↗ |
| Aug 19, 2026 | 4 | 4 | ↗ |
| Aug 19, 2026 | 4 | 4 | ↗ |
| Aug 19, 2026 | 4 | 4 | ↗ |
| Aug 19, 2026 | 4 | 4 | ↗ |
| Aug 19, 2026 | 4 | 4 | ↗ |
| Aug 19, 2026 | 4 | 4 | ↗ |
| Aug 19, 2026 | 4 | 4 | ↗ |
| Aug 14, 2026 | SCHEDULE 13G/A | ↗ | |
| Aug 13, 2026 | 10-Q | 10-Q | ↗ |
| Aug 13, 2026 | 8-K | Results of Operations (earnings); Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Jul 31, 2026 | 8-K | Item 3.03; Amendments to Bylaws/Charter; Financial Statements and Exhibits | ↗ |
| Jul 16, 2026 | 8-K | Entry into a Material Agreement; Termination of a Material Agreement; Material Direct Financial Obligation; Financial Statements and Exhibits | ↗ |
| Jun 29, 2026 | 3 | 3 | ↗ |
| Jun 23, 2026 | 8-K | Departure/Election of Directors or Officers; Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | ↗ |
| Jun 18, 2026 | 8-K | Item 5.07 | ↗ |
| Jun 5, 2026 | DEFA14A | DEFA14A | ↗ |
| May 29, 2026 | 8-K | Entry into a Material Agreement; Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| May 15, 2026 | SCHEDULE 13G | ↗ | |
| May 14, 2026 | 10-Q | 10-Q | ↗ |
| May 14, 2026 | 8-K | Results of Operations (earnings); Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| May 8, 2026 | 8-K | Entry into a Material Agreement; Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| Apr 29, 2026 | DEFA14A | DEFA14A | ↗ |
| Apr 29, 2026 | DEF 14A | DEF 14A | ↗ |
| Apr 17, 2026 | PRE 14A | PRE 14A | ↗ |
| Apr 2, 2026 | 8-K | Departure/Election of Directors or Officers; Other Events; Financial Statements and Exhibits | ↗ |
| Mar 31, 2026 | SCHEDULE 13D | ↗ | |
| Mar 27, 2026 | 10-K | 10-K | ↗ |
| Mar 27, 2026 | 8-K | Results of Operations (earnings); Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Mar 11, 2026 | 8-K | Entry into a Material Agreement; Unregistered Sale of Securities; Other Events; Financial Statements and Exhibits | ↗ |
| Mar 9, 2026 | SCHEDULE 13D | ↗ | |
| Mar 9, 2026 | 424B5 | 424B5 | ↗ |
| Mar 6, 2026 | 424B5 | 424B5 | ↗ |
| Mar 5, 2026 | S-3MEF | S-3MEF | ↗ |
| Feb 10, 2026 | SCHEDULE 13G/A | ↗ | |
| Feb 10, 2026 | 8-K | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Feb 4, 2026 | SCHEDULE 13G | ↗ | |
| Jan 29, 2026 | 8-K | Results of Operations (earnings); Other Events; Financial Statements and Exhibits | ↗ |